← Leaderboards
Shabbir Bakir Bambot
Guided Therapeutics
$8,308,831
Attributed
$8,308,831
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,308,831 · 7
By mechanism
R44$7,111,481 · 3
R43$1,197,350 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsImageTechnologyWomanDevicesBiopsyDesignDiagnosisResolutionBreastBaseEvaluationCancer EtiologyTumorSafetyScanningBreast Cancer DetectionPerformanceMammographyProductionDigital MammographyDoseDigital Breast TomosynthesisMalignant Breast Neoplasm
Grant awards (16)
MammoCAT Advanced Full Field Digital Mammography System$979,261
R44 · FY2023 · CA · contact PI
MammoCAT Advanced Full Field Digital Mammography System$1,023,397
R44 · FY2022 · CA · contact PI
I-Corps for Fischer Imaging's MammoCAT novel slot scanning mammography$55,000
R43 · FY2020 · CA · contact PI
3D CT Mammography using a Slot Scanning System$299,956
R43 · FY2019 · CA · contact PI
MammoCAT Advanced Full Field Digital Mammography System$1,695
R43 · FY2019 · CA · contact PI
MammoCAT Advanced Full Field Digital Mammography System$299,950
R43 · FY2018 · CA · contact PI
Intraoperative imaging of breast cancer margins using Polarization Subtraction Te$122,895
R43 · FY2014 · CA · contact PI
Intraoperative imaging of breast cancer margins using Polarization Subtraction Te$288,299
R43 · FY2013 · CA · contact PI
Economic Spectroscopic Evaluation of Cervical Cancer$1,000,000
R44 · FY2010 · CA · contact PI
Economic Spectroscopic Evaluation of Cervical Cancer$1,000,000
R44 · FY2009 · CA · contact PI
Multimodal Spectroscopic Evaluation of Cervical Cancer$690,829
R44 · FY2006 · CA · contact PI
Economic spectroscopic evaluation of Cervical Cancer$1,003,231
R44 · FY2005 · CA
Multimodal Spectroscopic Evaluation of Cervical Cancer.$634,125
R44 · FY2004 · CA
Economic spectroscopic evaluation of Cervical Cancer$101,625
R44 · FY2004 · CA
Multimodal Spectroscopic Evaluation of Cervical Cancer.$679,013
R44 · FY2003 · CA
MULTIMODAL SPECTROSCOPIC EVALUATION OF CERVICAL CANCER$129,555
R43 · FY2001 · CA